FF:NYSEFutureFuel Corp. Analysis
Data as of 2026-04-02 - not real-time
$4.18
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
FutureFuel Corp. trades at $4.18, just above its 20‑day SMA of 3.95 and comfortably above the 50‑day (3.89) and 200‑day (3.78) averages, indicating a short‑term bullish bias. Technical momentum is reinforced by a bullish MACD histogram (+0.029) and a neutral‑to‑slightly‑overbought RSI of 57, while the stock sits near the upper end of its support zone at 3.12 and below the resistance level of 4.64. Valuation appears attractive with a forward P/E of 5.2 and a price‑to‑book of 1.19**, yet the company reports steep negative margins (gross ‑41%, operating ‑63%) and a net loss of $49.4 million for 2025, raising questions about earnings sustainability. Despite a cash pile of $51 million and zero debt, operating cash flow remains deeply negative, and the recent reduction of the quarterly dividend to $0.01 per share undermines the headline 4.73% yield.
The stock’s risk profile is elevated: a 30‑day volatility of 74% and a beta around 0.48 signal price sensitivity, while the specialty chemicals sector faces cyclical demand and regulatory headwinds in biofuels. Geographic exposure is concentrated in the United States, limiting currency risk, but modest market capitalization (~$183 million) and average trading volumes suggest medium liquidity risk. Investors should weigh the technical upside against the fundamental weakness and high volatility when forming a position.
The stock’s risk profile is elevated: a 30‑day volatility of 74% and a beta around 0.48 signal price sensitivity, while the specialty chemicals sector faces cyclical demand and regulatory headwinds in biofuels. Geographic exposure is concentrated in the United States, limiting currency risk, but modest market capitalization (~$183 million) and average trading volumes suggest medium liquidity risk. Investors should weigh the technical upside against the fundamental weakness and high volatility when forming a position.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish technical alignment with SMAs and MACD
- Negative earnings and cash‑burn continue
- Dividend cut erodes yield credibility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Attractive forward P/E and price‑to‑book metrics
- Potential turnaround from capital reallocation to growth projects
- Debt‑free balance sheet provides flexibility
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- High volatility and sector cyclicality
- Uncertain path to sustainable profitability
- Continued exposure to biofuel policy and commodity price swings
Key Metrics & Analysis
Financial Health
Revenue Growth-67.70%
Profit Margin-51.59%
P/E Ratio5.2
ROE-27.40%
ROA-15.06%
P/B Ratio1.2
Op. Cash Flow$-28735000
Free Cash Flow$-49247376
Technical Analysis
TrendBullish
RSI57.0
Support$3.12
Resistance$4.64
MA 20$3.95
MA 50$3.89
MA 200$3.78
MACDBullish
VolumeIncreasing
Fear & Greed Index77.61
Valuation
GradeUndervalued
TypeValue
Dividend Yield4.73%
Risk Assessment
Beta0.48
Volatility74.23%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.